Platelet aggregation pathway enzymes

The platelet aggregation pathway involves a series of biochemical reactions and cellular interactions that lead to the formation of blood clots. Key enzymes and receptors in this pathway include the GPIIb/IIIa complex, which binds fibrinogen and von Willebrand factor, and the P2Y12 receptor, which is crucial for ADP-induced platelet aggregation. This pathway is a critical therapeutic target for preventing thrombotic events. Key Components of the Platelet Aggregation Pathway: 1. GPIIb/IIIa Complex: This integrin receptor is essential for platelet aggregation by binding fibrinogen and von Willebrand factor, facilitating platelet-platelet interactions[4][5]. 2. P2Y12 Receptor: A purinergic receptor activated by ADP, crucial for sustaining platelet aggregation. It is targeted by drugs like clopidogrel[2]. 3. Cyclooxygenase (COX) Enzymes: Involved in the production of thromboxane A2 (TXA2), which promotes platelet activation and aggregation. Aspirin inhibits COX enzymes to prevent platelet aggregation[2]. 4. Platelet Activation: Involves the release of granules containing chemokines and cytokines, which facilitate further platelet activation and interaction with other cells like monocytes[3].

Other names

Platelet aggregation pathwayPlatelet aggregation enzymes

Inhibition of ADP-induced platelet aggregation (e.g., by blocking P2Y12 receptors), inhibition of cyclooxygenase (COX) enzymes